Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone + CBT for Social and Spider Phobia
NCT01574014Phase 2Terminated
- Sponsor
- Insel Gruppe
- Start
- Jul 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Social Anxiety Disorder (SAD) and Specific phobia animal type comparing CBGT & Hydrocortisone with CBGT & Placebo (2 arms). Primary endpoint: Change from baseline in spider phobia symptoms / social phobia symptoms at 3 months. Started Jul 2009; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
Social Anxiety Disorder (SAD)Specific phobia animal type
Beyond the preview
Go deeper on NCT01574014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574014.